Women With Polycystic Ovary Syndrome Have an Increased Risk of Major Cardiovascular Events: a Population Study
Open accessThe DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Abstract
Context: The effects of polycystic ovary syndrome (PCOS) on cardiovascular morbidity and mortality are unclear. Objective: This work aims to establish the relative risk of myocardial infarction (MI), stroke, angina, revascularization, and cardiovascular mortality for women with PCOS. Methods: Data were extracted from the Clinical Practice Research Datalink Aurum database. Patients with PCOS were matched to controls (1:1) by age, body mass index (BMI) category, and primary care practice. The primary outcome was the time to major adverse cardiovascular event (MACE); a composite end point incorporating MI, stroke, angina, revascularization and cardiovascular mortality. Secondary outcomes were the individual MACE end points. Results: Of 219 034 individuals with a diagnosis of PCOS, 174 660 (79.7%) met the eligibility criteria and were matched. Crude rates of the composite end point, MI, stroke, angina, revascularization, and cardiovascular mortality were respectively 82.7, 22.7, 27.4, 32.8, 10.5, and 6.97 per 100 000 patient-years for cases, and 64.3, 15.9, 25.7, 19.8, 7.13, and 7.75 per 100 000 patient-years for controls. In adjusted Cox proportional hazard models (CPHMs), the hazard ratios (HRs) were 1.26 (95% CI, 1.13-1.41), 1.38 (95% CI, 1.11-1.72), 1.60 (95% CI, 1.32-1.94), and 1.50 (95% CI, 1.08-2.07) for the composite outcome, MI, angina, and revascularization, respectively. In a time-dependent CPHM, weight gain (HR 1.01; 1.00-1.01), prior type 2 diabetes mellitus (T2DM) (HR 2.40; 1.76-3.30), and social deprivation (HR 1.53; 1.11-2.11) increased risk of progression to the composite end point. Conclusion: The risk of incident MI, angina, and revascularization is increased in young women with PCOS. Weight and T2DM are potentially modifiable risk factors amenable to intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PCOS is associated with increased co-morbidities including obesity, infertility, pregnancy complications, depression and anxiety, metabolic syndrome, diabetes, reproductive cancers and cardiovascular disease [3, 7, 8, 10–13].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Women with PCOS experience increased cardiometabolic risk—including the metabolic syndrome, hypertension, insulin resistance, obesity and dyslipidemia—predisposing them to increased risk for diabetes and cardiovascular disease (CVD).2,10,17, 18, 19, 20”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The diagnosis of PCOS included the ICD-9 and ICD-10 codes, and these have been validated and used in previous epidemiologic studies.6,10,17,27,32,55, 56, 57”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427 · cited 1×
“A substudy of the Women’s Ischemia Evaluation Study demonstrated that women with PCOS had a higher prevalence of multivessel cardiovascular disease (CVD), and significantly lower cardiovascular event-free survival, than controls (9), results that were later retracted because of a failure to replicate these findings (1…”
BackgroundRetracted(2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4415 · Cited by 6 · cited 1×
“A sub-study of the Women’s Ischemia Evaluation Study demonstrated that women with PCOS had a higher prevalence of multivessel cardiovascular disease, and significantly lower cardiovascular event-free survival, than controls (9), results which were later retracted due to a failure to replicate these findings (10) but w…”
RetractedCharlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742 · cited 1×
“The CPHM models included the following covariates (all were available and tested for inclusion in each model): age, BMI category, smoking status, alcohol status, type 2 diabetes (T2DM), baseline morbidity represented by the Charlson index (25), systolic and diastolic blood pressure, and relative deprivation based on q…”
MethodReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Principles and Practice of Screening for Disease.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-5-1085_2 · Cited by 3,066 · cited 1×
“Screening would only be beneficial if it led to earlier identification of risk factors amenable to modification, in turn leading to improved outcomes (40).”
BackgroundTeede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823
Principles and Practice of Screening for Disease.
Zavon, M. R. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.1969.00300130131020 · Cited by 1,356 · cited 1×
“Screening would be beneficial only if it led to the earlier identification of risk factors amenable to modification, in turn leading to improved outcomes (40).”
BackgroundWild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970 · cited 1×
“We (1) and others (21, 22) have previously failed to show an increased risk of cardiovascular events in women with PCOS, albeit that these studies were likely underpowered since the crude incidence of cardio- and cerebrovascular events in this young female population is low.”
BackgroundCardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872 · cited 1×
“Insulin resistance, which is highly prevalent in lean as well as obese women with PCOS, increases adipose tissue lipolysis (26), leading to dyslipidemia, and vasoconstriction, due to reduced endothelial nitric oxide production (27).”
BackgroundData resource profile: Clinical Practice Research Datalink (CPRD) Aurum
Wolf, A., Dedman, D., Campbell, J., Booth, H., Lunn, D., Chapman, J., & Myles, P. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz034 · Cited by 861 · cited 1×
“This study included patients identified by CPRD as being of an acceptable research quality (23), who were identified by diagnosis codes from both CPRD Aurum and HES, and who were eligible for linkage to the secondary care data.”
MethodTalbott, E. O., Guzick, D. S., Sutton-Tyrrell, K., McHugh-Pemu, K. P., Zborowski, J. V., Remsberg, K. E., & Kuller, L. H. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.11.2414 · Cited by 511 · cited 2×
“Accordingly, PCOS is associated with increased endothelial dysfunction (6), arterial stiffness (8), and carotid intima media thickness (5), yet it is unclear whether these surrogate measures translate into increased vascular morbidity and mortality.”
BackgroundMortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
Pierpoint, T., McKeigue, P. M., Isaacs, A. J., Wild, S. H., & Jacobs, H. S. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00035-3 · Cited by 504 · cited 1×
“We (1) and others (21, 22) have previously failed to show an increased risk of cardiovascular events in women with PCOS, albeit that these studies were likely underpowered since the crude incidence of cardio- and cerebrovascular events in this young female population is low.”
BackgroundCoronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome
Talbott, E., Guzick, D., Clerici, A., Berga, S., Detre, K., Weimer, K., & Kuller, L. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.7.821 · Cited by 504 · cited 2×
“Endocrinol Metab 2018;103(4):1622-1630.”
BackgroundLong-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis
Wekker, V, van Dammen, L., Koning, A., Heida, K. Y., Painter, R. C., Limpens, J., Laven, J. S. E., Roeters van Lennep, J. E., Roseboom, T. J., & Hoek, A. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa029 · Cited by 425 · cited 3×
“In a recent systematic review and meta-analysis of observational longitudinal studies comparing fatal and non-fatal CVD events in women with and without PCOS (32), the risk of coronary events was not different between groups, whereas non-fatal cerebrovascular events were higher in women with PCOS.”
BackgroundResultEpidemiology and Adverse Cardiovascular Risk Profile of Diagnosed Polycystic Ovary Syndrome
Lo, J. C., Feigenbaum, S. L., Yang, J., Pressman, A. R., Selby, J. V., & Go, A. S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2430 · Cited by 414 · cited 1×
“This contrasts with the findings of Lo et al who compared the prevalence of diagnosed CVD (coronary heart disease, cerebrovascular disease and peripheral vascular disease) among 11,035 women with PCOS and 55,175 age-matched controls in an integrated health care delivery system in northern California (33).”
Resultde Groot, P. C. M., Dekkers, O. M., Romijn, J. A., Dieben, S. W. M., & Helmerhorst, F. M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr001 · Cited by 394 · cited 3×
“However, two of the earlier meta-analyses were compromised by the inclusion of data that were later retracted (11, 12), whilst adjustment for BMI, a potentially major confounder in this patient population, abolished the increased risk of stroke reported in another (30).”
ResultThe Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
Hart, R., & Doherty, D. A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3886 · Cited by 391 · cited 3×
“9 reported an increased risk of hospitalization for ischemic heart disease and cerebrovascular disease in their study of 2,566 women with PCOS and 25,660 age-matched women without a diagnosis of PCOS in Western Australia (15).”
BackgroundInfluentialCarmina, E., Chu, M. C., Longo, R. A., Rini, G. B., & Lobo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2279 · Cited by 274 · cited 1×
“Previous studies have suggested that cardiovascular risk factors are more prevalent in PCOS patients with irregular cycles (44), but additional studies are needed to establish whether this leads to differences among phenotypes in clinical events.”
BackgroundTalbott, E. O., Zborowski, J. V., Rager, J. R., Boudreaux, M. Y., Edmundowicz, D. A., & Guzick, D. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032237 · Cited by 273 · cited 1×
“Studies have shown that surrogate markers of cardiovascular risk are increased in patients with PCOS, including carotid intima media thickness (5), endothelial dysfunction (6), coronary artery calcification (7) and arterial stiffness (8).”
BackgroundOverweight Women with Polycystic Ovary Syndrome Have Evidence of Subclinical Cardiovascular Disease
Meyer, C., McGrath, B. P., & Teede, H. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0011 · Cited by 273 · cited 2×
“Studies have shown that surrogate markers of cardiovascular risk are increased in patients with PCOS, including carotid intima media thickness (5), endothelial dysfunction (6), coronary artery calcification (7) and arterial stiffness (8).”
BackgroundSchmidt, J., Landin-Wilhelmsen, K., Brännström, M., & Dahlgren, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1677 · Cited by 241 · cited 1×
“Other population-based studies have been limited by comparatively small sample sizes and/or a failure to adjust for important confounders such as obesity (13-20).”
BackgroundCardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
Glintborg, D., Rubin, K. H., Nybo, M., Abrahamsen, B., & Andersen, M. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0680-5 · Cited by 200 · cited 1×
“In a Danish national register-based study (35), involving 18,112 patients and 52,769 controls, the adjusted hazard ratio for incident CVD (excluding hypertension and dyslipidemia) was 1.”
BackgroundMani, H., Levy, M. J., Davies, M. J., Morris, D. H., Gray, L. J., Bankart, J., Blackledge, H., Khunti, K., & Howlett, T. A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12068 · Cited by 194 · cited 1×
“Other population-based studies have been limited by comparatively small sample sizes and/or a failure to adjust for important confounders such as obesity (13-20).”
BackgroundSampson, M., Kong, C., Patel, A., Unwin, R., & Jacobs, H. S. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00863.x · Cited by 186 · cited 1×
“In addition to insulin resistance, women with PCOS display a range of metabolic and vascular risk factors, including central obesity (2), hypertension (3) and dyslipidaemia (4), which are commonly present at a young age.”
BackgroundOllila, M.-M. E., Piltonen, T., Puukka, K., Ruokonen, A., Järvelin, M.-R., Tapanainen, J. S., Franks, S., & Morin-Papunen, L. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3543 · Cited by 182 · cited 1×
“Intervention at an early age may be especially important in light of data showing increased weight gain in early adulthood in women with PCOS compared to controls (38).”
BackgroundBarber, T. M., Golding, S. J., Alvey, C., Wass, J. A. H., Karpe, F., Franks, S., & McCarthy, M. I. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2117 · Cited by 179
Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis.
Zhao, L., Zhu, Z., Lou, H., Zhu, G., Huang, W., Zhang, S., & Liu, F. (2016) · Oncotarget · doi:10.18632/oncotarget.9553 · Cited by 174
The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?
Lansdown, A., & Rees, D. A. (2012) · Clinical Endocrinology · doi:10.1111/cen.12003 · Cited by 165 · cited 1×
“Hyperinsulinemia may also lead to sympathoexcitation, with consequent actions on increased renal water retention and blood pressure elevation (28), whilst defects in insulin secretion as well as insulin action contribute to an increased risk of type 2 diabetes (1).”
BackgroundGlintborg, D., Hass Rubin, K., Nybo, M., Abrahamsen, B., & Andersen, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1108 · Cited by 154 · cited 2×
“Our findings are largely in agreement with another population-based study, in which patients with PCOS had a higher prevalence of a recorded diagnosis of stroke, diabetes, dyslipidemia and hypertension than controls, whereas the risks of a diagnosis of cardiovascular disease (CVD), myocardial infarction and transitory…”
BackgroundResultSprung, V. S., Atkinson, G., Cuthbertson, D. J., Pugh, C. J. A., Aziz, N., Green, D. J., Cable, N. T., & Jones, H. (2013) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04490.x · Cited by 142 · cited 2×
“Studies have shown that surrogate markers of cardiovascular risk are increased in patients with PCOS, including carotid intima media thickness (5), endothelial dysfunction (6), coronary artery calcification (7) and arterial stiffness (8).”
BackgroundMorgan, C. L., Jenkins-Jones, S., Currie, C. J., & Rees, D. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1690 · Cited by 136 · cited 6×
“In our previous examination of the CPRD dataset, we found no evidence of an increased incidence of large vessel disease in women with PCOS (1), albeit that the number of patients studied was considerably smaller (n=21,740) than the current study.”
BackgroundResultInfluentialSelf-citationMeun, C., Franco, O. H., Dhana, K., Jaspers, L., Muka, T., Louwers, Y., Ikram, M. A., Fauser, B. C. J. M., Kavousi, M., & Laven, J. S. E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02421 · Cited by 126 · cited 2×
“An analysis of any effect on vascular events in PCOS patients after the menopausal transition would also be of interest, since hyperandrogenism and metabolic disturbances persist despite amelioration of the clinical features with age (18).”
BackgroundRoberts, S., Barry, E., Craig, D., Airoldi, M., Bevan, G., & Greenhalgh, T. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017184 · Cited by 122 · cited 10×
“The CPHM models included the following covariates (all were available and tested for inclusion in each model): age, BMI category, smoking status, alcohol status, type 2 diabetes (T2DM), baseline morbidity represented by the Charlson index (25), systolic and diastolic blood pressure, and relative deprivation based on q…”
BackgroundInfluentialZhang, J., Xu, J.-H., Qu, Q.-Q., & Zhong, G.-Q. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.552421 · Cited by 96 · cited 2×
“Our finding of an increased risk of cardiovascular events is consistent with some (11, 24, 29, 30, 31), but not all (12, 32), previous meta-analyses which have examined the risk of coronary heart disease, stroke and/or cardiovascular mortality in this population.”
ResultRamezani Tehrani, F., Amiri, M., Behboudi-Gandevani, S., Bidhendi-Yarandi, R., & Carmina, E. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1650337 · Cited by 91 · cited 3×
“Our finding of an increased risk of cardiovascular events is consistent with some (11, 24, 29, 30, 31), but not all (12, 32), previous meta-analyses which have examined the risk of coronary heart disease, stroke and/or cardiovascular mortality in this population.”
BackgroundResultMerz, C. N. B., Shaw, L. J., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2016) · Journal of Women's Health · doi:10.1089/jwh.2015.5441 · Cited by 87 · cited 1×
“Other population-based studies have been limited by comparatively small sample sizes and/or a failure to adjust for important confounders such as obesity (13-20).”
BackgroundHillman, J., Johnson, L. N. C., Limaye, M. A., Feldman, R., Sammel, M. D., & Dokras, A. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.10.055 · Cited by 86 · cited 1×
“This is an important area of further study in view of the recognized influence of ethnicity on cardiometabolic risk factors in women with PCOS as in the general population (42, 43).”
BackgroundEpidemiology and Comorbidities of Polycystic Ovary Syndrome in an Indigent Population
Sirmans, S. M., Parish, R. C., Blake, S., & Wang, X. (2014) · Journal of Investigative Medicine · doi:10.1097/01.jim.0000446834.90599.5d · Cited by 79 · cited 1×
“Other population-based studies have been limited by comparatively small sample sizes and/or a failure to adjust for important confounders such as obesity (13-20).”
BackgroundAnderson, S. A., Barry, J. A., & Hardiman, P. J. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.06.079 · Cited by 77 · cited 3×
“Our finding of an increased risk of cardiovascular events is consistent with some (11, 24, 29-31), but not all (12, 32), previous meta-analyses that have examined the risk of coronary heart disease, stroke, and/or cardiovascular mortality in this population.”
BackgroundResultCoronary artery disease risk in young women with polycystic ovary syndrome
Ding, D., Tsai, I., Wang, J., Lin, S., & Sung, F. (2018) · Oncotarget · doi:10.18632/oncotarget.23985 · Cited by 69 · cited 1×
“Other population-based studies have been limited by comparatively small sample sizes and/or a failure to adjust for important confounders such as obesity (13-20).”
BackgroundZhou, Y., Wang, X., Jiang, Y., Ma, H., Chen, L., Lai, C., Peng, C., He, C., & Sun, C. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1347779 · Cited by 64 · cited 2×
“However, two of the earlier meta-analyses were compromised by the inclusion of data that were later retracted (11, 12), whilst adjustment for BMI, a potentially major confounder in this patient population, abolished the increased risk of stroke reported in another (30).”
ResultKim, J. Y., Tfayli, H., Michaliszyn, S. F., & Arslanian, S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01958 · Cited by 55 · cited 1×
“Insulin resistance, which is highly prevalent in lean as well as obese women with PCOS, increases adipose tissue lipolysis (26), leading to dyslipidemia, and vasoconstriction, due to reduced endothelial nitric oxide production (27).”
BackgroundRheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis
Fransen, J., Kazemi‐Bajestani, S. M. R., Bredie, S. J. H., & Popa, C. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157360 · Cited by 53 · cited 1×
“This contrasts with the higher relative- and absolute risk reported in young patients with rheumatoid arthritis (34).”
ResultChang, A. Y., Oshiro, J., Ayers, C. R., & Auchus, R. J. (2015) · Clinical Endocrinology · doi:10.1111/cen.12986 · Cited by 43 · cited 1×
“This is an important area of further study in view of the recognized influence of ethnicity on cardiometabolic risk factors in women with PCOS as in the general population (42, 43).”
Background
Research works printed but not linked: 1
- Barber, 2008, Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome, J Clin Endocrinol Metab., 93, 999, 10.1210/jc.2007-2117 · DOI · Paper page
Cited by
Joham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00163-2 · Cited by 838
Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00511-3 · Cited by 495
“Large data sets now indicate potentially increased risk for major cardiovascular end points 12,35 , including myocardial infarction, stroke, heart failure and cardiovascular mortality 12,35,50 .”
Polycystic Ovary Syndrome: Pathophysiology and Therapeutic Opportunities
Dong, J., & Rees, D. A. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2023-000548 · Cited by 123
“1 These health risks could be associated with an increased risk of cardiovascular events 86 and several adverse pregnancy outcomes.”
Adipose Tissue Dysfunction in Polycystic Ovary Syndrome
Bril, F., Ezeh, U., Amiri, M., Hatoum, S., Pace, L., Chen, Y.-H., Bertrand, F., Gower, B., & Azziz, R. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad356 · Cited by 123
Ollila, M.-M., Arffman, R. K., Korhonen, E., Morin-Papunen, L., Franks, S., Junttila, J., & Piltonen, T. T. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad077 · Cited by 108
Metadata
- Authors
- Berni, T. R., Morgan, C. L., & Rees, D. A.
- Affiliations
- Pharmatelligence, Cardiff CF24 3FR, UK
- Neuroscience and Mental Health Research Institute, School of Medicine, Cardiff University, Cardiff CF24 4HQ, UK
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2021-06-01
- Volume
- 106
- Issue
- 9
- Pages
- e3369-e3380
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC8372630
- OpenAlex
- W3165367402
- Cited by
- 146
- References
- 45
- Citations by year
- 2026: 36 · 2025: 37 · 2024: 26 · 2023: 27 · 2022: 10 · 2021: 10
- FWCI
- 15.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- polycystic ovary syndrome, major adverse cardiovascular events, myocardial infarction, stroke, angina pectoris, revascularization, cardiovascular mortality, cardiovascular risk factors, type 2 diabetes, social deprivation, weight gain, women's cardiovascular health, Clinical Practice Research Datalink Aurum, matched cohort comparison, body mass index, hypertriglyceridemia, hyperinsulinemia
- MeSH terms
- Adult, Angina Pectoris, Cardiovascular Diseases, Female, Humans, Myocardial Infarction, Myocardial Revascularization, Polycystic Ovary Syndrome, Population, Primary Health Care, Retrospective Studies, Cohort Studies, Weight Gain, Body Mass Index, Proportional Hazards Models, Risk Assessment, Stroke, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

